Company intelligence / Profile preview

Midsouth Investors Fund

Memphis, Tennessee, United States

Ownership: Private
Development stage: Other

Overview

Midsouth Investors Fund is a private investment partnership and venture capital firm that focuses on identifying high-growth opportunities, with a significant emphasis on the healthcare and biotechnology sectors. The fund is known for its value-oriented investment strategy, often taking substantial equity positions in publicly traded and private life science companies to drive long-term value. Managed by Midsouth Capital Management, the fund leverages deep industry expertise to support its portfolio companies through strategic guidance and capital allocation. It has historically been involved in significant investments in companies such as BioCryst Pharmaceuticals and Aclaris Therapeutics.

Industry: Investors

Beyond the preview

Go deeper on Midsouth Investors Fund.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Midsouth Investors Fund.

Explore the full profile